Clinical trial
Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem
NCT00492726 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00492726 |
|---|---|
| Title | Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem |
| Official title | A Prospective, Randomized, Double-dummy, Double-blind, Multicenter Trial Comparing the Safety and Efficacy of Intravenous Moxifloxacin 400 mg IV QD 24 Hours to That of Ertapenem 1.0 g IV QD 24 Hours for 5 to 14 Days for the Treatment of Subjects With Complicated Intra-abdominal Infections (PROMISE… |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infection |
| Intervention type | Drug |
| Interventions | Moxifloxacin (Avelox, BAY12-8039), Ertapenem intravenous |
| Enrollment | 804 |
| Start date | Jul 1, 2006 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Jun 27, 2007 |
| Last update posted | Nov 7, 2014 |
| Countries | Argentina, Belgium, Bulgaria, Estonia, France, Germany, Greece, Israel, Latvia, Lithuania, Romania, Russia and 2 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: